BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3128553)

  • 1. Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.
    Snelling CF; Roberts FJ
    J Burn Care Rehabil; 1988; 9(1):35-40. PubMed ID: 3128553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds.
    Gray JH; Henry DA; Forbes M; Germann E; Roberts FJ; Snelling CF
    Burns; 1991 Feb; 17(1):37-40. PubMed ID: 2031672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns.
    Snelling CF; Inman RJ; Germann E; Boyle JC; Foley B; Kester DA; Fitzpatrick DJ; Warren RJ; Courtemanche AD
    J Burn Care Rehabil; 1991; 12(1):13-8. PubMed ID: 2022674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
    Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
    Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection.
    Inman RJ; Snelling CF; Roberts FJ; Shaw K; Boyle JC
    Burns Incl Therm Inj; 1984 Oct; 11(1):35-40. PubMed ID: 6391611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
    J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
    Modak S; Fox CL
    J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of the local application of silver sulfadiazine, cefsulodin and povidone-iodine in burns].
    Kaiser W; von der Lieth H; Potel J; Heymann H
    Infection; 1984; 12(1):31-5. PubMed ID: 6706410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of different topical agents on pseudomonas infection of burn wound].
    Guo Z; Gao W; He L
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Nov; 11(6):421-4. PubMed ID: 8728928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
    Acikel C; Oncul O; Ulkur E; Bayram I; Celikoz B; Cavuslu S
    J Burn Care Rehabil; 2003; 24(1):37-41. PubMed ID: 12543989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
    Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
    Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriological effect of cerium-flamazine cream in major burns.
    Boeckx W; Focquet M; Cornelissen M; Nuttin B
    Burns Incl Therm Inj; 1985 Jun; 11(5):337-42. PubMed ID: 4027748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo comparison of two silver sulfadiazine antimicrobial agents on burn wound infection.
    Velanovich V; Heggers JP; Robson MC; Zoellner SM; McHugh TP; Boertman J; Niu XT; Schileru R
    J Burn Care Rehabil; 1987; 8(5):381-3. PubMed ID: 3667664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical chlorhexidine diphosphanilate (WP-973) in burn wound sepsis.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1984 Feb; 119(2):206-11. PubMed ID: 6421265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of topical therapeutic effect between silver norfloxacin (Ag-NFL) and silver sulfadiazine (Ag-SD) in treatment of pyocyaneous sepsis in burn rats].
    Huo ZL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1993 Mar; 9(2):118-20, 159. PubMed ID: 8221304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing.
    Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM
    Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.